The Patent Finder

Terms ending in 2039

Jazz Pharmaceuticals, Inc.

Every in-force patent on Jazz Pharmaceuticals, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,413,264Carbamoyl Phenylalaninol Analogs and Uses Thereof
In force
 · High confidence
Axsome Malta Ltd.In forceHigh confidence
US 11,456,081Sensitive Drug Distribution Systems and Methods
In force
 · High confidence
Jazz Pharmaceuticals, Inc.In forceHigh confidence
US 11,571,440Defibrotide for the Prevention and Treatment of Cytokine Release Syndrome and Neurotoxicity Associated with Immunodepletion
Richardson, Paul G.
In force
 · High confidence
Richardson, Paul G.In forceHigh confidence
US 11,400,052Alcohol-Resistant Drug Formulations
In force
 · High confidence
Jazz Pharmaceuticals Ireland LimitedIn forceHigh confidence
US 12,440,449Alcohol-Resistant Drug Formulations
In force
 · High confidence
Jazz Pharmaceuticals Ireland LimitedIn forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Jazz Pharmaceuticals, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited